International Flavors & Fragrances Inc banner

International Flavors & Fragrances Inc
XMUN:IFF

Watchlist Manager
International Flavors & Fragrances Inc Logo
International Flavors & Fragrances Inc
XMUN:IFF
Watchlist
Price: 73.82 EUR -0.78%
Market Cap: €18.9B

International Flavors & Fragrances Inc
Investor Relations

International Flavors & Fragrances makes the scent and taste ingredients that go inside other companies’ products. It sells flavor systems for foods and drinks, fragrance compounds for perfumes, personal care, and household products, and specialty ingredients used in health, wellness, and industrial applications. Its customers are mainly consumer packaged goods companies, food and beverage makers, personal care brands, and manufacturers that need a specific ingredient profile or sensory effect. IFF makes money by selling these ingredients and by designing custom formulas for customers. In many cases, it works closely with a customer to match a taste, smell, texture, or performance target, then supplies that formula over time as part of the customer’s production chain. This means the business is less about selling to end consumers and more about being a behind-the-scenes supplier that helps big brands create finished products. What makes IFF different is that its products are often built into a customer’s recipe or manufacturing process, which can make them hard to replace. The company’s role sits in the middle of the value chain: it combines chemistry, application know-how, and manufacturing to turn raw materials into specialized ingredients that other companies use in their own branded goods.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Aug 5, 2026
AI Summary
Q2 2026

Results: IFF reported a solid second quarter, with continuing operations revenue of just under $2 billion, up roughly 6%, and EBITDA of $408 million, up 6%. Growth was volume-led across all three core businesses.

Guidance: The company raised its full-year 2026 outlook on a continuing operations basis, now expecting sales of $7.4 billion to $7.6 billion and EBITDA of $1.53 billion to approximately $1.6 billion.

Portfolio shift: Management framed the Food Ingredients divestiture as a major step toward a simpler, higher-growth portfolio focused on Taste, Scent, and Health & Biosciences, with no significant divestitures left to do.

Capital returns: IFF plans to use more than $1 billion of proceeds to reduce debt and has authorized a $2.5 billion share repurchase program, including about $500 million expected in the second half of 2026.

Margins and cash: Stranded costs of about $100 million will temporarily pressure margins, but management expects to remove about 2/3 of those costs within 12 months after close. First-half free cash flow rose to $378 million, up $284 million year over year.

Macro backdrop: Management said consumer demand has remained resilient, but it is still watching Middle East volatility and modest input cost inflation, especially in energy and logistics.

Key Financials
Revenue
just under $2 billion
EBITDA
$408 million
Sales growth
4% in the first half
EBITDA growth
8% in the first half
Free cash flow
$378 million
Cash and cash equivalents
$569 million
Gross debt
approximately $5.7 billion
Net debt to credit adjusted EBITDA
2.5x
Taste sales
$688 million
Taste EBITDA
$124 million
Health & Biosciences sales
$601 million
Health & Biosciences EBITDA
$150 million
Scent sales
$665 million
Scent EBITDA
$134 million
Cash from operations
$679 million
CapEx
$301 million
Share repurchase program
$2.5 billion
Debt reduction from proceeds
more than $1 billion
Food Ingredients divestiture value
about $4.3 billion
Stranded costs
about $100 million
Additional botanical extracts and vitamins business sales
about $170 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Glenn Robert Richter
Executive VP and Chief Financial & Business Transformation Officer
No Bio Available
Dr. Jennifer Amy Johnson Ph.D.
Executive VP, General Counsel & Corporate Secretary
No Bio Available
Mr. Simon Herriott
President of Health & Biosciences
No Bio Available
Mr. Yuvraj Arora
Executive VP & President of Nourish
No Bio Available
Mr. Jon Erik Fyrwald
CEO & Director
No Bio Available
Mr. Ralf Finzel Ph.D.
Executive VP & Global Operations Officer
No Bio Available
Ms. Beril Yildiz
Senior VP, Corporate Controller & Chief Accounting Officer
No Bio Available
Mr. Michael DeVeau
Senior Vice President of Corporate Finance & Investor Relations
No Bio Available
Mr. Vic Verma
Executive VP & Chief Information Officer
No Bio Available
Ms. Deborah Borg
Executive VP and Chief Human Resources, Communications and Diversity, Equity & Inclusion Officer
No Bio Available

Contacts

Address
NEW YORK
New York City
521 W 57th St
Contacts
+12127655500.0
www.iff.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett